Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Current Deferred Revenue: 2018-2022

Historic Current Deferred Revenue for Zai Lab (ZLAB) over the last 2 years, with Mar 2022 value amounting to $26.9 million.

  • Zai Lab's Current Deferred Revenue rose 61.47% to $26.9 million in Q1 2022 from the same period last year, while for Mar 2022 it was $26.9 million, marking a year-over-year increase of 61.47%. This contributed to the annual value of $27.5 million for FY2021, which is 63.04% up from last year.
  • As of Q1 2022, Zai Lab's Current Deferred Revenue stood at $26.9 million, which was down 2.15% from $27.5 million recorded in Q4 2021.
  • Over the past 5 years, Zai Lab's Current Deferred Revenue peaked at $27.5 million during Q4 2021, and registered a low of $607,000 during Q2 2019.
  • Its 3-year average for Current Deferred Revenue is $19.8 million, with a median of $17.5 million in 2021.
  • As far as peak fluctuations go, Zai Lab's Current Deferred Revenue crashed by 62.58% in 2019, and later spiked by 2,492.42% in 2020.
  • Over the past 5 years, Zai Lab's Current Deferred Revenue (Quarterly) stood at $2.1 million in 2018, then skyrocketed by 39.58% to $2.9 million in 2019, then spiked by 485.14% to $16.9 million in 2020, then surged by 63.04% to $27.5 million in 2021, then surged by 61.47% to $26.9 million in 2022.
  • Its Current Deferred Revenue stands at $26.9 million for Q1 2022, versus $27.5 million for Q4 2021 and $17.5 million for Q3 2021.